CIK 0000882095
- Large accelerated filer
GILEAD SCIENCES, INC.
Sign in to watch- Ticker
- GILD
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943047598
- Phone
- +1 650-574-3000
- Business address
- 333 LAKESIDE DR, FOSTER CITY, CA, 94404
- Former names
- GILEAD SCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $35,234,659
- in 11 filings, $35.2M under 10b5-1 plans
Net −$35,234,659. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- O'Day Daniel Patrick −$29.5M Chairman & CEO sold 24% of stake
- WELTERS ANTHONY −$2.7M Director sold 58% of stake
- Dickinson Andrew D −$905K Chief Financial Officer sold 4% of stake
- Mercier Johanna −$901K Chief Comm & Corp Aff Officer sold 5% of stake
- Bluestone Jeffrey −$725K Director sold 33% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-12-13 | Patterson Sandra SVP, Controllership | Option exercise | +117 | 37,376 | ||
| 2023-12-13 | Patterson Sandra SVP, Controllership | Shares withheld for taxes | −298 | $83.09 | $25K | 37,235 |
| 2023-12-13 | Patterson Sandra SVP, Controllership | Option exercise · Restricted Stock Unit | −181 | 12,101 | ||
| 2023-12-13 | Patterson Sandra SVP, Controllership | Option exercise · Restricted Stock Unit | −117 | 11,984 |
Page 30 of 30 · 584 trades